Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Find out more about Cancellations and Suspensions.
Search
85 result(s) found, displaying 51 to 75
-
Cancellation or suspensionRegulatory action due to The Device is automatically cancelled from the Register, on the basis that the ARTG entry had been suspended from the Register under section 41GA and the period applying to the suspension under subsections 41GA(3) and 41GC(3) has expired before the suspension was revoked., effective 31/05/2016
-
Cancellation or suspensionRegulatory action due to , effective 16/05/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 16/05/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 16/05/2016
-
Cancellation or suspensionRegulatory action due to The sponsor did not provide evidence that the Device is safe or performs as intended, nor did the Sponsor provide information to substantiate compliance with the Essential Principles; the sponsor failed to comply with conditions to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a)., effective 02/05/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods., effective 28/04/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/04/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 18/04/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 04/04/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 04/04/2016
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect.It appeared to the Secretary that the presentation of the goods was unacceptable., effective 23/03/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 09/03/2016
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) of the Act was incorrect.The sponsor failed to comply with a condition of listing under s.28(5)(ab) of the Act (that the goods would not be advertised for an indication other than those accepted in the Register)., effective 08/03/2016
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) of the Act was incorrect., effective 02/03/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the presentation of the goods was unacceptable.As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect.The goods do not conform to a standard applicable to the goods., effective 26/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
Last updated